the characteristics and prognosis of SBC. Patients and Methods Using the SEER database, 3,407 patients were identified who received BCS ± RT for primary DCIS in 2000 through 2013 and subsequently developed a stage I–III invasive SBC within the same
Search Results
Puyao C. Li, Zilu Zhang, Angel M. Cronin, and Rinaa S. Punglia
Kuan-Ling Kuo, David Stenehjem, Frederick Albright, Saurabh Ray, and Diana Brixner
at least 2 encounters in the EDW, with 1 encounter at least 30 days from the index date ( Figure 1 , available online, in this article, at JNCCN.org ). Demographic characteristics (age, sex, race, plan type, region) were recorded on index date and
Daneng Li, Can-Lan Sun, Heeyoung Kim, Christiana Crook, Ya-Han Zhang, Rebecca Allen, Richard Ballena, Shadman Hyder, Marianna Koczywas, Vincent Chung, Dean Lim, Vani Katheria, William Dale, and Gagandeep Singh
/treatment characteristics. The proportions and 95% confidence intervals of patients choosing survival, function/independence, freedom from pain, or freedom from symptoms as their most important treatment goal on the Health Outcomes Tool were calculated. Patient opinions on
Andrea Maurichi, Francesco Barretta, Roberto Patuzzo, Rosalba Miceli, Gianfranco Gallino, Ilaria Mattavelli, Consuelo Barbieri, Andrea Leva, Martina Angi, Francesco Baldo Lanza, Giuseppe Spadola, Mara Cossa, Francesco Nesa, Umberto Cortinovis, Laura Sala, Lorenza Di Guardo, Carolina Cimminiello, Michele Del Vecchio, Barbara Valeri, and Mario Santinami
predictors associated with a more aggressive clinical behavior in patients with positive SNs, particularly with regard to metastatic involvement of further non-SNs. Some of these analyses of factors for higher invasiveness focused on characteristics of the
Adam J. Widman, Bevin Cohen, Vivian Park, Tara McClure, Jedd Wolchok, and Mini Kamboj
-agent pembrolizumab. No patients experienced a flare of a prior irAE after vaccination. Table 2 compares characteristics of patients who did versus did not experience an irAE. No significant differences in baseline characteristics or treatment were seen between
Joseph A. Greer, Jamie M. Jacobs, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Molly E. Ream, Emily A. Walsh, Joanne Buzaglo, Alona Muzikansky, Inga T. Lennes, Steven A. Safren, William F. Pirl, and Jennifer S. Temel
higher scores indicating greater perceived social support. Statistical Analyses SPSS Statistics, version 22.0 (IBM Corp) was used to conduct the analyses. Patient baseline characteristics were described using measures of central tendency or proportions
Alexander P. Cole, Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz, Brandon A. Mahal, Paul L. Nguyen, Toni K. Choueiri, Adam S. Kibel, Adil H. Haider, and Quoc-Dien Trinh
-level covariates included age, sex (where applicable), race (white, black, other, unknown), and marital status. Other demographic variables included income, residence type, and education (based on subjects’ county of residence). Tumor characteristics included
Carlotta Palumbo, Francesco A. Mistretta, Sophie Knipper, Angela Pecoraro, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Claudio Simeone, Alberto Briganti, Alessandro Antonelli, and Pierre I. Karakiewicz
). Results General Characteristics of the Study Population From 2001 through 2015, 77,892 patients with nmRCC were identified, 26,562 (34.1%) of whom were treated with partial nephrectomy and 51,330 (65.9%) with radical nephrectomy. Stage distribution was as
Helmneh M. Sineshaw, K. Robin Yabroff, V. Liana Tsikitis, Ahmedin Jemal, and Timur Mitin
study period by diagnosis year. Statistical Analysis We conducted descriptive analyses for patient characteristics by age group. We calculated the proportion of patients who died within 30 days, 90 days, and 6 months after surgical treatment by age
Kyuwan Lee, Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh, Meagan Echevarria, Sophia Albanese, Liezl Atencio, Rusha Bhandari, F. Lennie Wong, Andrew S. Artz, Tanya Siddiqi, Liana Nikolaenko, Jasmine Zain, Matthew Mei, Geoffrey Shouse, Leslie L. Popplewell, Alex F. Herrera, L. Elizabeth Budde, Stephen J. Forman, and Saro H. Armenian
and L. Atencio), who were blinded to patient characteristics and outcomes. Muscle area was normalized for height (cm 2 /m 2 ) 28 and reported as lumbar skeletal muscle index (SMI). Skeletal muscle radiodensity (SMD), typically used to determine
